Skip to content
CNS Clinical Research

District of Columbia

CNS clinical trials in District of Columbia

33 CNS studies are recruiting participants at sites in 1 city across District of Columbia as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every District of Columbia city with a recruiting study

By research area: Depression (7), Multiple Sclerosis (7), Migraine (6), Parkinson's Disease (6), Epilepsy (3), ADHD (2), Schizophrenia (2).

Washington D.C. (33).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in District of Columbia

Basic details from each study's public record (the 12 most recently updated of 33). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Washington D.C.
    Registry record
    NCT06748222 · updated
  2. A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Recruiting in
    Washington D.C.
    Registry record
    NCT07227454 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in District of Columbia on ClinicalTrials.gov.

ADHD: recently updated in District of Columbia

  1. The Myelin Disorders Biorepository Project

    • Observational
    • All ages
    • All sexes
    Sponsor
    Children's Hospital of Philadelphia
    Recruiting in
    Washington D.C.
    Registry record
    NCT03047369 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in District of Columbia on ClinicalTrials.gov.

Parkinson's disease: recently updated in District of Columbia

  1. A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Washington D.C.
    Registry record
    NCT06841354 · updated
  2. A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Washington D.C.
    Registry record
    NCT06952504 · updated
  3. A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

    • Phase 3
    • Ages 50 to 85
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Washington D.C.
    Registry record
    NCT07174310 · updated
  4. A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

    • Phase 3
    • Ages 45 to 75
    • All sexes
    Sponsor
    BlueRock Therapeutics
    Recruiting in
    Washington D.C.
    Registry record
    NCT06944522 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in District of Columbia on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in District of Columbia

  1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Washington D.C.
    Registry record
    NCT03816345 · updated
  2. A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    TG Therapeutics, Inc.
    Recruiting in
    Washington D.C.
    Registry record
    NCT06433752 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in District of Columbia on ClinicalTrials.gov.

Epilepsy: recently updated in District of Columbia

  1. Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Neurona Therapeutics
    Recruiting in
    Washington D.C.
    Registry record
    NCT05135091 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in District of Columbia on ClinicalTrials.gov.

Migraine: recently updated in District of Columbia

  1. Dietary Intervention for Migraine Relief

    • No phase
    • Ages 18 to 75
    • All sexes
    Sponsor
    American University
    Recruiting in
    Washington D.C.
    Registry record
    NCT07360405 · updated
  2. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Washington D.C.
    Registry record
    NCT04649242 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in District of Columbia on ClinicalTrials.gov.

Ask about studies in District of Columbia

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call